why choose us

First received: March 02, 2023

Clinical Trial: Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Study Status: Completed

Recruit Status: RECRUITING

Condition: Urothelial Carcinoma

Study Type: INTERVENTIONAL


Official Title: Phase 1 Clinical Trial of Intravesical Adoptive Cell Therapy {ACT) With Tumor Infiltrating Lymphocytes (TIL) for Patients With BCG Exposed High Grade Non-Muscle Invasive Bladder Cancer (NMIBC)

Brief Summary: The purpose of the study is to evaluate the feasibility, safety and tolerability of intravesical adoptive cell therapy using TIL (tumor infiltrating lymphocytes) in participants with urothelial cell carcinoma (UCC) non-muscle invasive bladder cancer (NMIBC).

Read more